Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J GREENBLATT

Showing results (861-870 of 874) with videos related to

Pageof 88
Sort By:
Journal of the American Dental Association (1939)|April 28, 2006
Balancing efficacy and safety in the use of oral sedation in dental outpatientsRaymond A Dionne, John A Yagiela, Charles J Coté, et al.
Clinical Pharmacology and Therapeutics|December 2, 1998
Comparative kinetics and dynamics of zaleplon, zolpidem, and placeboD J Greenblatt, J S Harmatz, L L von Moltke, et al.
Nature Communications|February 19, 2025
Mass spectrometry methods and mathematical PK/PD model for decision tree-guided covalent drug developmentMd Amin Hossain, Rutali R Brahme, Brandon C Miller, et al.
Journal of Clinical Pharmacology|April 9, 2002
Limited sampling strategy to predict AUC of the CYP3A phenotyping probe midazolam in adults: application to various assay techniquesJooran S Kim, Anne N Nafziger, Shirley M Tsunoda, et al.
Antimicrobial Agents and Chemotherapy|July 24, 2019
Effect of First-Line Antituberculosis Therapy on Nevirapine Pharmacokinetics in Children Younger than Three Years OldAnthony Enimil, Sampson Antwi, Hongmei Yang, et al.
Antimicrobial Agents and Chemotherapy|November 7, 2018
Effect of Rifampin-Isoniazid-Containing Antituberculosis Therapy on Efavirenz Pharmacokinetics in HIV-Infected Children 3 to 14 Years OldAwewura Kwara, Hongmei Yang, Sampson Antwi, et al.
Journal of Clinical Pharmacology|April 29, 2014
Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosisYanli Zhao, Merit E Cudkowicz, Jeremy M Shefner, et al.
Plos One|April 25, 2013
Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosisJames D Berry, Jeremy M Shefner, Robin Conwit, et al.
Neurology|February 26, 2016
A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progressionMichael D Weiss, Eric A Macklin, Zachary Simmons, et al.
Science (New York, N.Y.)|October 20, 1995
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 yearsR M Blaese, K W Culver, A D Miller, et al.
Pageof 88

Showing results (861-870 of 874) with videos related to

Sort By:
Pageof 88
Journal of the American Dental Association (1939)|April 28, 2006
Balancing efficacy and safety in the use of oral sedation in dental outpatientsRaymond A Dionne, John A Yagiela, Charles J Coté, et al.
Clinical Pharmacology and Therapeutics|December 2, 1998
Comparative kinetics and dynamics of zaleplon, zolpidem, and placeboD J Greenblatt, J S Harmatz, L L von Moltke, et al.
Nature Communications|February 19, 2025
Mass spectrometry methods and mathematical PK/PD model for decision tree-guided covalent drug developmentMd Amin Hossain, Rutali R Brahme, Brandon C Miller, et al.
Journal of Clinical Pharmacology|April 9, 2002
Limited sampling strategy to predict AUC of the CYP3A phenotyping probe midazolam in adults: application to various assay techniquesJooran S Kim, Anne N Nafziger, Shirley M Tsunoda, et al.
Antimicrobial Agents and Chemotherapy|July 24, 2019
Effect of First-Line Antituberculosis Therapy on Nevirapine Pharmacokinetics in Children Younger than Three Years OldAnthony Enimil, Sampson Antwi, Hongmei Yang, et al.
Antimicrobial Agents and Chemotherapy|November 7, 2018
Effect of Rifampin-Isoniazid-Containing Antituberculosis Therapy on Efavirenz Pharmacokinetics in HIV-Infected Children 3 to 14 Years OldAwewura Kwara, Hongmei Yang, Sampson Antwi, et al.
Journal of Clinical Pharmacology|April 29, 2014
Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosisYanli Zhao, Merit E Cudkowicz, Jeremy M Shefner, et al.
Plos One|April 25, 2013
Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosisJames D Berry, Jeremy M Shefner, Robin Conwit, et al.
Neurology|February 26, 2016
A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progressionMichael D Weiss, Eric A Macklin, Zachary Simmons, et al.
Science (New York, N.Y.)|October 20, 1995
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 yearsR M Blaese, K W Culver, A D Miller, et al.
Pageof 88